Elixxer Ltd. (ELIXF)
Elixxer Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.03, up 0.00% on the session, giving a market capitalisation of $3.2M. On trailing twelve-month figures it carries a trailing P/E of -0.14, a net margin of 0.0%. Its beta of -0.54 implies it has historically moved less than the broad market.
Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.
Elixxer Ltd. is most often compared with the following Healthcare names: